Advertisement
News
Advertisement

I Wanna Be Sublatedâ„¢ Road to Rejuvenationâ„¢ World Tour Prepares to Rock All Ages Through a New Facial Rejuvenation Category.

Mon, 08/22/2011 - 3:55am
Bio-Medicine.Org

IRVINE, Calif., Aug. 22, 2011 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the global leader in medical aesthetic devices, kicks off the rock of all ages tour with the introduction of The I Wanna Be Sublated, Road to Rejuvenation World Tour – a consumer awareness campaign developed to inspire and revolutionize the landscape of anti-aging with a novel, non-surgical, treatment category in facial rejuvenation - Sublative®.  "Sublative rejuvenation is the byproduct of countless product development discussions with the brightest minds in Dermatology and Plastic Surgery," said Louis P. Scafuri, Chief Executive Officer of Syneron.  "The driving topic remains centered on what we can do to meet the needs of our customers' patient base and inspire exciting and innovative advancements in our field. Physicians and patients have come to agree that Sublative is the answer to both points."

At first glance the Sublative treatment is already sparking new light for future aesthetic applications as the world's first treatment powered solely by fractionated, bi-polar radio-frequency.  "Syneron's expertise as an innovator of radio-frequency technology spans over a decade," said James Bartholomeusz, Global Vice President of Product Development of Syneron.  "Our Sublative technology is the latest evolution to captivate the facial rejuvenation world with a novel treatment that transcends through all skin types and age groups. Its versatility amplified with effectiveness positions Sublative as the ideal treatment for the modern-day patient on the go."

Safe and effective for all skin types and age groups, experts will agree that Sublative stands alone in energy-based facial cosmetic applications due to its unique energy delivery model.  "To achieve the best possible results when addressing skin imperfections it is essential that the energy reaches bel

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading